Exhibit 23.1
Consent of Independent Auditors
We consent to the incorporation by reference in the following Registration Statements of Agenus Inc.:
|
| |
| (1) | Registration Statement (Form S-8 No. 333-40440) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 1999 Employee Stock Purchase Plan |
| (2) | Registration Statement (Form S-8 No. 333-40442) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 1999 Equity Incentive Plan |
| (3) | Registration Statement (Form S-8 No. 333-50434) pertaining to the Agenus Inc. (formerly Antigenics Inc.) Aquila Biopharmaceuticals Inc. 1996 Stock Award and Option Plan and 1996 Directors Stock Award and Option Plan as assumed by Antigenics Inc. |
| (4) | Registration Statement (Form S-8 No. 333-69580) pertaining to the Agenus Inc. (formerly Antigenics Inc.) Aronex Pharmaceuticals Inc. amended and restated 1998 Stock Option Plan as assumed by Antigenics Inc. |
| (5) | Registration Statement (Form S-8 No. 333-106072) pertaining to the Agenus Inc. (formerly Antigenics Inc.) Directors’ Deferred Compensation Plan |
| (6) | Registration Statement (Form S-8 No. 333-115984) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 1999 Equity Incentive Plan |
| (7) | Registration Statement (Form S-8 No. 333-143807) pertaining to the Agenus Inc. (formerly Antigenics Inc.) Directors’ Deferred Compensation Plan |
| (8) | Registration Statement (Form S-8 No. 333-143808) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 1999 Employee Stock Purchase Plan |
| (9) | Registration Statement (Form S-8 No. 333-151745) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 1999 Equity Incentive Plan |
| (10) | Registration Statement (Form S-8 No. 333-160084) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 2009 Equity Incentive Plan |
| (11) | Registration Statement (Form S-8 No. 333-160087) pertaining to the Agenus Inc. (formerly Antigenics Inc.) 2009 Employee Stock Purchase Plan |
| (12) | Registration Statement (Form S-8 No. 333-160088) pertaining to the Agenus Inc. (formerly Antigenics Inc.) Directors’ Deferred Compensation Plan |
| (13) | Registration Statement (Form S-8 No. 333-176609) pertaining to the Agenus Inc. Directors’ Deferred Compensation Plan |
| (14) | Registration Statement (Form S-8 No. 333-183066) pertaining to the Agenus Inc. 2009 Equity Incentive Plan |
| (15) | Registration Statement (Form S-8 No. 333-183067) pertaining to the Agenus Inc. Directors’ Deferred Compensation Plan |
| (16) | Registration Statement (Form S-8 No. 333-189926) pertaining to the Agenus Inc. 2009 Equity Incentive Plan |
| (17) | Registration Statement (Form S-3/A and S-1- No. 333-161277) pertaining to the Agenus Inc. (formerly Antigenics Inc.) prospectus for the registration of 9,673,900 Shares of Common Stock |
| (18) | Registration Statement (Form S-3 No. 333-163221) pertaining to the Agenus Inc. (formerly Antigenics Inc.) prospectus for the registration of 8,552,632 Shares of Common Stock |
| (19) | Registration Statement (Form S-3/A and S-3 No. 333-185657) pertaining to the Agenus Inc. prospectus for the registration of $150,000,000 of Common Stock, Preferred Stock, Warrants and Debt Securities Units |
| (20) | Registration Statement (Form S-3 No. 333-189534) pertaining to the Agenus Inc. prospectus for the registration of 500,000 shares of common stock |
of our report dated March 12, 2014, with respect to the financial statements of 4-Antibody AG for the year ended December 31, 2013 included in this Form 8-K/A.
|
| | |
| /s/ Ernst & Young Ltd. | |
| Basel, Switzerland | |
| April 29, 2014 | |
